Clinical Trial

Microneedling for Skin Heath

Completed Phase 4
View on ClinicalTrials.gov →
Summary
Skin boosters are treatments designed to improve skin quality and restore skin health. Some of these treatments are based on polynucleotides, which are small fragments of DNA. One such compound, called Polydeoxyribonucleotide (PDRN), is obtained from fish sources such as salmon or trout. PDRN has shown regenerative and anti-inflammatory properties, and in medical practice it has been used to support wound healing, scar improvement, and skin rejuvenation by helping with elasticity, texture, and fine lines. VAMP™ Multivitamin Serum is a topical formulation that contains PDRN along with amino acids, vitamins, and peptides. It is designed to improve hydration, elasticity, and overall skin radiance. While early data suggest potential benefits, clinical research is still limited, and further study is needed.
Protocol Amendment History 3 changes
critical Trial completed 2026-07-08
notable Primary completion pushed: 2026-06-01 -> 2026-07-02 2026-07-08
minor Completion pushed: 2026-06-01 -> 2026-07-02 2026-07-08
Trial Details
NCT Number NCT07210190
Lead Sponsor Erevna Innovations Inc.
Conditions Aesthetic
Enrollment 30 participants
Start Date 2026-01-17
Primary Completion 2026-07-02 (estimated)
Study Completion 2026-07-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-07